Breaking News Instant updates and real-time market news.

NUWE

Nuwellis

/

+

17:19
09/09/22
09/09
17:19
09/09/22
17:19

Nuwellis files to sell Class A and Class B units, no amount given

Ladenburg Thalmann is acting as sole book-running manager for the offering.

  • 15

    Sep

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Dr. Martens price target lowered to 270 GBp from 375 GBp at Barclays » 14:03
11/28/22
11/28
14:03
11/28/22
14:03
DOCMF

Dr. Martens

$2.60 /

-0.877 (-25.24%)

Barclays analyst Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCMF Dr. Martens
$2.60 /

-0.877 (-25.24%)

11/25/22 Morgan Stanley
Dr. Martens price target lowered to 250 GBp from 276 GBp at Morgan Stanley
06/15/22 RBC Capital
Dr. Martens price target raised to 380 GBp from 375 GBp at RBC Capital
04/13/22 Barclays
Dr. Martens price target lowered to 360 GBp from 480 GBp at Barclays
02/07/22 Peel Hunt
Dr. Martens upgraded to Add from Hold at Peel Hunt
Recommendations
Unite Group price target lowered to 1,050 GBp from 1,075 GBp at JPMorgan » 14:03
11/28/22
11/28
14:03
11/28/22
14:03
UTGPF

Unite Group

$10.04 /

+ (+0.00%)

JPMorgan analyst Neil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UTGPF Unite Group
$10.04 /

+ (+0.00%)

10/13/22 RBC Capital
Unite Group initiated with an Outperform at RBC Capital
09/16/22 JPMorgan
Unite Group downgraded to Neutral from Overweight at JPMorgan
09/01/22 Morgan Stanley
Unite Group upgraded to Overweight from Equal Weight at Morgan Stanley
07/27/22 Peel Hunt
Unite Group downgraded to Reduce from Add at Peel Hunt
Recommendations
Jack in the Box price target lowered to $80 from $96 at Stifel » 14:01
11/28/22
11/28
14:01
11/28/22
14:01
JACK

Jack in the Box

$72.58 /

+0.05 (+0.07%)

Stifel analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JACK Jack in the Box
$72.58 /

+0.05 (+0.07%)

JACK Jack in the Box
$72.58 /

+0.05 (+0.07%)

11/23/22 Truist
Jack in the Box price target lowered to $88 from $100 at Truist
11/23/22 Deutsche Bank
Jack in the Box price target lowered to $75 from $88 at Deutsche Bank
11/23/22 Wedbush
Jack in the Box price target lowered to $100 from $115 at Wedbush
11/23/22 Citi
Jack in the Box price target lowered to $75 from $88 at Citi
JACK Jack in the Box
$72.58 /

+0.05 (+0.07%)

JACK Jack in the Box
$72.58 /

+0.05 (+0.07%)

JACK Jack in the Box
$72.58 /

+0.05 (+0.07%)

Conference/Events
Pros Holdings management to meet virtually with Northland » 13:55
11/28/22
11/28
13:55
11/28/22
13:55
PRO

Pros Holdings

$22.60 /

+0.12 (+0.53%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRO Pros Holdings
$22.60 /

+0.12 (+0.53%)

PRO Pros Holdings
$22.60 /

+0.12 (+0.53%)

09/09/22 Northland
Pros Holdings elevated to 'Top Pick' at Northland
07/29/22 Craig-Hallum
Pros Holdings price target lowered to $30 from $35 at Craig-Hallum
07/29/22 Baird
Pros Holdings price target lowered to $30 from $40 at Baird
06/08/22
Baird to hold a conference
PRO Pros Holdings
$22.60 /

+0.12 (+0.53%)

Options
Restaurant Brands put volume heavy and directionally bearish » 13:55
11/28/22
11/28
13:55
11/28/22
13:55
QSR

Restaurant Brands

$65.80 /

-0.6 (-0.90%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QSR Restaurant Brands
$65.80 /

-0.6 (-0.90%)

QSR Restaurant Brands
$65.80 /

-0.6 (-0.90%)

11/22/22 RBC Capital
Restaurant Brands price target raised to $80 from $70 at RBC Capital
11/21/22 Morgan Stanley
Restaurant Brands upgraded to Equal Weight from Underweight at Morgan Stanley
11/04/22 Goldman Sachs
Restaurant Brands upgraded to Neutral from Sell at Goldman Sachs
10/20/22 Barclays
Restaurant Brands price target lowered to $65 from $68 at Barclays
QSR Restaurant Brands
$65.80 /

-0.6 (-0.90%)

QSR Restaurant Brands
$65.80 /

-0.6 (-0.90%)

QSR Restaurant Brands
$65.80 /

-0.6 (-0.90%)

QSR Restaurant Brands
$65.80 /

-0.6 (-0.90%)

Conference/Events
Thomson Reuters to hold an investor webcast » 13:55
11/28/22
11/28
13:55
11/28/22
13:55
TRI

Thomson Reuters

$116.17 /

+0.205 (+0.18%)

President & CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRI Thomson Reuters
$116.17 /

+0.205 (+0.18%)

TRI Thomson Reuters
$116.17 /

+0.205 (+0.18%)

11/02/22 BMO Capital
Thomson Reuters price target raised to $165 from $160 at BMO Capital
08/05/22 Canaccord
Thomson Reuters price target raised to $122 from $115 at Canaccord
07/01/22 Barclays
Thomson Reuters price target lowered to $115 from $125 at Barclays
06/14/22 CIBC
Thomson Reuters upgraded to Outperformer from Neutral at CIBC
TRI Thomson Reuters
$116.17 /

+0.205 (+0.18%)

Recommendations
Catalent VAI update addresses Brussels shutdown concerns, says Morgan Stanley » 13:47
11/28/22
11/28
13:47
11/28/22
13:47
CTLT

Catalent

$44.44 /

+3.09 (+7.47%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTLT Catalent
$44.44 /

+3.09 (+7.47%)

CTLT Catalent
$44.44 /

+3.09 (+7.47%)

12:55 Today Barclays
Catalent had 483s cleared, removing overhang, says Barclays
11/07/22 Argus
Catalent downgraded to Hold at Argus amid guidance cut, weaker end-markets
11/07/22 Argus
Catalent downgraded to Hold from Buy at Argus
11/02/22 RBC Capital
Catalent price target lowered to $73 from $125 at RBC Capital
CTLT Catalent
$44.44 /

+3.09 (+7.47%)

CTLT Catalent
$44.44 /

+3.09 (+7.47%)

CTLT Catalent
$44.44 /

+3.09 (+7.47%)

Options
InMode call volume above normal and directionally bullish » 13:45
11/28/22
11/28
13:45
11/28/22
13:45
INMD

InMode

$35.62 /

-0.36 (-1.00%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INMD InMode
$35.62 /

-0.36 (-1.00%)

INMD InMode
$35.62 /

-0.36 (-1.00%)

10/12/22 Jefferies
InMode initiated with a Buy at Jefferies
07/29/22 Baird
InMode price target raised to $53 from $44 at Baird
07/13/22 Baird
InMode price target lowered to $44 from $57 at Baird
06/30/22 Canaccord
InMode price target lowered to $40 from $50 at Canaccord
INMD InMode
$35.62 /

-0.36 (-1.00%)

INMD InMode
$35.62 /

-0.36 (-1.00%)

INMD InMode
$35.62 /

-0.36 (-1.00%)

Conference/Events
Vera Therapeutics to hold a KOL virtual event » 13:45
11/28/22
11/28
13:45
11/28/22
13:45
VERA

Vera Therapeutics

$16.04 /

-0.31 (-1.90%)

Management holds a Key…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VERA Vera Therapeutics
$16.04 /

-0.31 (-1.90%)

VERA Vera Therapeutics
$16.04 /

-0.31 (-1.90%)

08/22/22 H.C. Wainwright
Vera Therapeutics price target raised to $36 from $35 at H.C. Wainwright
07/12/22 JPMorgan
Vera Therapeutics initiated with an Overweight at JPMorgan
05/02/22 H.C. Wainwright
Vera Therapeutics initiated with a Buy at H.C. Wainwright
04/18/22 Wedbush
Vera Therapeutics initiated with an Outperform at Wedbush
VERA Vera Therapeutics
$16.04 /

-0.31 (-1.90%)

  • 10
    Feb
Conference/Events
Portage Biotech participates in a conference call with Cantor Fitzgerald » 13:45
11/28/22
11/28
13:45
11/28/22
13:45
PRTG

Portage Biotech

$5.75 /

-0.3 (-4.96%)

Biotech Analyst Watsek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTG Portage Biotech
$5.75 /

-0.3 (-4.96%)

PRTG Portage Biotech
$5.75 /

-0.3 (-4.96%)

09/20/22 H.C. Wainwright
Portage Biotech price target lowered to $22 from $32 at H.C. Wainwright
07/15/22 Oppenheimer
Portage Biotech assumed with an Outperform at Oppenheimer
03/07/22 H.C. Wainwright
Portage Biotech initiated with a Buy at H.C. Wainwright
PRTG Portage Biotech
$5.75 /

-0.3 (-4.96%)

PRTG Portage Biotech
$5.75 /

-0.3 (-4.96%)

PRTG Portage Biotech
$5.75 /

-0.3 (-4.96%)

General news
November Dallas Fed manufacturing survey production index 0.8  13:40
11/28/22
11/28
13:40
11/28/22
13:40
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Options
Organigram Holdings options imply 19.6% move in share price post-earnings » 13:34
11/28/22
11/28
13:34
11/28/22
13:34
OGI

Organigram

$1.00 /

-0.02 (-1.96%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OGI Organigram
$1.00 /

-0.02 (-1.96%)

OGI Organigram
$1.00 /

-0.02 (-1.96%)

07/15/22 Stifel
Organigram price target lowered to C$1.50 from C$2.25 at Stifel
07/15/22 Alliance Global Partners
Organigram price target lowered to C$1.50 from C$2.25 at Alliance Global
01/13/22 Stifel
Organigram price target lowered to C$2.25 from C$2.75 at Stifel
01/12/22 Canaccord
Organigram upgraded to Speculative Buy from Hold at Canaccord
OGI Organigram
$1.00 /

-0.02 (-1.96%)

Periodicals
Sony to supply Apple with latest image sensor for next iPhone, Nikkei reports » 13:27
11/28/22
11/28
13:27
11/28/22
13:27
SONY

Sony

$82.63 /

-0.37 (-0.45%)

, AAPL

Apple

$144.81 /

-3.34 (-2.25%)

Sony (SONY) will supply…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SONY Sony
$82.63 /

-0.37 (-0.45%)

AAPL Apple
$144.81 /

-3.34 (-2.25%)

SONY Sony
$82.63 /

-0.37 (-0.45%)

11/02/22 Cowen
Sony price target lowered to $102 from $144 at Cowen
10/13/22 Oppenheimer
Oppenheimer sees more difficulty for Microsoft/Activision to win CMA approval
09/07/22 Goldman Sachs
Sony resumed with a Neutral at Goldman Sachs
07/08/22 Macquarie
Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie
AAPL Apple
$144.81 /

-3.34 (-2.25%)

07:39 Today Wedbush
Apple iPhone shortages build into holiday season, says Wedbush
11/23/22 Wedbush
iPhone demand into Black Friday may put Apple in 'major shortage,' says Wedbush
11/22/22 Canaccord
Apple iPhone demand remains strong, supply could be issue, says Canaccord
11/21/22 JPMorgan
Apple likely past trough for iPhone Pro supply, says JPMorgan
SONY Sony
$82.63 /

-0.37 (-0.45%)

AAPL Apple
$144.81 /

-3.34 (-2.25%)

SONY Sony
$82.63 /

-0.37 (-0.45%)

AAPL Apple
$144.81 /

-3.34 (-2.25%)

SONY Sony
$82.63 /

-0.37 (-0.45%)

AAPL Apple
$144.81 /

-3.34 (-2.25%)

SONY Sony
$82.63 /

-0.37 (-0.45%)

AAPL Apple
$144.81 /

-3.34 (-2.25%)

Recommendations
Axsome's positive data may provide path for earlier sNDA filing, says Ladenburg » 13:25
11/28/22
11/28
13:25
11/28/22
13:25
AXSM

Axsome Therapeutics

$73.65 /

+17.03 (+30.08%)

After Axsome Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$73.65 /

+17.03 (+30.08%)

AXSM Axsome Therapeutics
$73.65 /

+17.03 (+30.08%)

11:35 Today Guggenheim
Axsome Therapeutics study met primary, secondary endpoints, says Guggenheim
11/09/22 Mizuho
Axsome Therapeutics price target raised to $80 from $76 at Mizuho
11/08/22 Cantor Fitzgerald
Axsome Therapeutics price target raised to $96 from $88 at Cantor Fitzgerald
11/01/22 Loop Capital
Axsome Therapeutics initiated with a Buy at Loop Capital
AXSM Axsome Therapeutics
$73.65 /

+17.03 (+30.08%)

AXSM Axsome Therapeutics
$73.65 /

+17.03 (+30.08%)

AXSM Axsome Therapeutics
$73.65 /

+17.03 (+30.08%)

Options
Vodafone call volume above normal and directionally bullish » 13:25
11/28/22
11/28
13:25
11/28/22
13:25
VOD

Vodafone

$11.16 /

-0.11 (-0.98%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VOD Vodafone
$11.16 /

-0.11 (-0.98%)

VOD Vodafone
$11.16 /

-0.11 (-0.98%)

11/22/22 Credit Suisse
Vodafone downgraded to Underperform from Outperform at Credit Suisse
11/21/22 Jefferies
Vantage Towers downgraded to Hold from Buy at Jefferies
11/18/22 Barclays
Vodafone price target lowered to 110 GBp from 120 GBp at Barclays
10/05/22 JPMorgan
Vodafone price target lowered to 120 GBp from 165 GBp at JPMorgan
VOD Vodafone
$11.16 /

-0.11 (-0.98%)

VOD Vodafone
$11.16 /

-0.11 (-0.98%)

VOD Vodafone
$11.16 /

-0.11 (-0.98%)

Options
Provident Bancorp options imply 12.9% move in share price post-earnings » 13:19
11/28/22
11/28
13:19
11/28/22
13:19
PVBC

Provident Bancorp

$6.97 /

-0.1 (-1.41%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PVBC Provident Bancorp
$6.97 /

-0.1 (-1.41%)

PVBC Provident Bancorp
$6.97 /

-0.1 (-1.41%)

11/16/22 Stephens
Provident Bancorp downgraded to Equal Weight from Overweight at Stephens
03/28/22 Stephens
Provident Bancorp initiated with an Overweight at Stephens
PVBC Provident Bancorp
$6.97 /

-0.1 (-1.41%)

PVBC Provident Bancorp
$6.97 /

-0.1 (-1.41%)

PVBC Provident Bancorp
$6.97 /

-0.1 (-1.41%)

PVBC Provident Bancorp
$6.97 /

-0.1 (-1.41%)

Technical Analysis
NASDAQ market internals summary » 13:17
11/28/22
11/28
13:17
11/28/22
13:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Conference/Events
Grid Dynamics management to meet with Needham » 13:16
11/28/22
11/28
13:16
11/28/22
13:16
GDYN

Grid Dynamics

$12.51 /

+0.13 (+1.05%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDYN Grid Dynamics
$12.51 /

+0.13 (+1.05%)

GDYN Grid Dynamics
$12.51 /

+0.13 (+1.05%)

11/04/22 Citi
Grid Dynamics price target lowered to $18 from $27 at Citi
10/14/22 JPMorgan
Grid Dynamics price target lowered to $22 from $27 at JPMorgan
05/09/22 Northland
Grid Dynamics price target raised to $25 from $22.50 at Northland
05/06/22 Citi
Grid Dynamics price target raised to $23 from $20 at Citi
  • 08
    Sep
GDYN Grid Dynamics
$12.51 /

+0.13 (+1.05%)

Technical Analysis
NYSE market internals summary » 13:16
11/28/22
11/28
13:16
11/28/22
13:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Options
Mondelez put volume heavy and directionally bearish » 13:15
11/28/22
11/28
13:15
11/28/22
13:15
MDLZ

Mondelez

$66.44 /

-0.28 (-0.42%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDLZ Mondelez
$66.44 /

-0.28 (-0.42%)

MDLZ Mondelez
$66.44 /

-0.28 (-0.42%)

11/15/22 Exane BNP Paribas
Mondelez initiated with a Neutral at Exane BNP Paribas
11/02/22 Morgan Stanley
Mondelez price target raised to $69 from $63 at Morgan Stanley
11/02/22 Deutsche Bank
Mondelez price target raised to $72 from $70 at Deutsche Bank
10/31/22 Mizuho
Mondelez price target lowered to $70 from $75 at Mizuho
MDLZ Mondelez
$66.44 /

-0.28 (-0.42%)

MDLZ Mondelez
$66.44 /

-0.28 (-0.42%)

MDLZ Mondelez
$66.44 /

-0.28 (-0.42%)

MDLZ Mondelez
$66.44 /

-0.28 (-0.42%)

Recommendations
Trainline price target raised to 480 GBp from 460 GBp at Berenberg » 13:14
11/28/22
11/28
13:14
11/28/22
13:14
TNLIF

Trainline

$3.40 /

+ (+0.00%)

Berenberg analyst Owen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TNLIF Trainline
$3.40 /

+ (+0.00%)

11/18/22 Morgan Stanley
Trainline price target lowered to 370 GBp from 435 GBp at Morgan Stanley
11/07/22 Deutsche Bank
Trainline price target lowered to 350 GBp from 371 GBp at Deutsche Bank
11/04/22 JPMorgan
Trainline price target raised to 403 GBp from 370 GBp at JPMorgan
10/18/22 JPMorgan
Trainline price target lowered to 370 GBp from 425 GBp at JPMorgan
Recommendations
Senior plc price target lowered to 140 GBp from 150 GBp at Berenberg » 13:13
11/28/22
11/28
13:13
11/28/22
13:13
SNIRF

Senior plc

$1.35 /

-0.069491 (-4.90%)

Berenberg analyst Ross…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNIRF Senior plc
$1.35 /

-0.069491 (-4.90%)

11/21/22 JPMorgan
Senior plc price target lowered to 155 GBp from 160 GBp at JPMorgan
07/15/22 Barclays
Senior plc upgraded to Overweight from Underweight at Barclays
03/03/22 Berenberg
Senior plc price target lowered to 150 GBp from 180 GBp at Berenberg
02/18/22 Credit Suisse
Senior plc price target lowered to 190 GBp from 200 GBp at Credit Suisse
Recommendations
Novo Nordisk price target raised to DKK 810 from DKK 780 at Berenberg » 13:13
11/28/22
11/28
13:13
11/28/22
13:13
NVO

Novo Nordisk

$120.25 /

+0.85 (+0.71%)

Berenberg analyst Luisa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVO Novo Nordisk
$120.25 /

+0.85 (+0.71%)

NVO Novo Nordisk
$120.25 /

+0.85 (+0.71%)

11/03/22 Credit Suisse
Novo Nordisk price target raised to DKK 860 from DKK 820 at Credit Suisse
10/14/22 Barclays
Novo Nordisk price target raised to DKK 850 from DKK 825 at Barclays
09/28/22 Oddo BHF
Novo Nordisk upgraded to Outperform from Neutral at Oddo BHF
09/14/22 Piper Sandler
Piper 'surprised' by negative Altimmune reaction after pemvidutide's 'big win'
NVO Novo Nordisk
$120.25 /

+0.85 (+0.71%)

NVO Novo Nordisk
$120.25 /

+0.85 (+0.71%)

NVO Novo Nordisk
$120.25 /

+0.85 (+0.71%)

Recommendations
K+S AG price target raised to EUR 25 from EUR 23 at Berenberg » 13:12
11/28/22
11/28
13:12
11/28/22
13:12
KPLUY

K+S AG

$11.15 /

+0.354 (+3.28%)

Berenberg analyst Adrien…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KPLUY K+S AG
$11.15 /

+0.354 (+3.28%)

11/21/22 JPMorgan
K+S AG price target lowered to EUR 26 from EUR 38 at JPMorgan
11/11/22 Scotiabank
K+S AG downgraded to Underperform from Sector Perform at Scotiabank
10/18/22 Baader Helvea
K+S AG upgraded to Buy from Add at Baader Helvea
10/05/22 JPMorgan
K+S AG price target lowered to EUR 38 from EUR 44.50 at JPMorgan
Recommendations
Fielmann price target lowered to EUR 27 from EUR 30 at Berenberg » 13:12
11/28/22
11/28
13:12
11/28/22
13:12
FLMNF

Fielmann

$30.00 /

+ (+0.00%)

Berenberg analyst Graham…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLMNF Fielmann
$30.00 /

+ (+0.00%)

11/23/22 HSBC
Fielmann price target lowered to EUR 37 from EUR 41 at HSBC
11/03/22 Oddo BHF
Fielmann downgraded to Neutral from Outperform at Oddo BHF
09/06/22 Berenberg
Fielmann price target lowered to EUR 30 from EUR 41 at Berenberg
07/05/22 HSBC
Fielmann downgraded to Hold from Buy at HSBC

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.